Thomas Horacek

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 142 citations · Full text

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults

Tino F. Schwarz, Thomas Horacek, Markus Knuf et al. · Vaccine · 2009 · 118 citations

Vaccinology, Vaccination, Cross-protection +11

NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction

Domingo A. Pascual‐Figal, Rolf Wachter, Michele Senni et al. · JACC Heart Failure · 2020 · 33 citations · Full text

Factors Associated With Treatment Acceptance and Compliance Among Incarcerated Male Sex Offenders

Carl Clegg, William J. Fremouw, Thomas Horacek et al. · International Journal of Offender Therapy and Comparative Criminology · 2010 · 21 citations